FORMULATION OF CLOTRIMAZOLE ORORETENTIVE JELLY

Journal Title: Journal of Drug Delivery and Therapeutics - Year 2016, Vol 6, Issue 2

Abstract

Objective: Patient compliance and ease of administration are of significant importance in the design of dosage forms. Dysphasia is common among all age groups, especially in elderly and pediatrics. There are dosage forms like tablets, syrups in the market but still there is a need for new dosage form which acts effectively and locally. Jellies can provide an attractive alternative formulation in the treatment of oral candidiasis. So the present investigation aims to design, prepare and evaluate Clotrimazole jellies using xanthan gum with different concentrations. The benefits of these prepared jellies are increased bioavailability by-passing first pass metabolism. Method: The sucrose based jellies were prepared by heating and congealing method. Physical characteristics, pH, syneresis, in vitro dissolution testing, drug release kinetics, IR Spectral analysis and stability studies were conducted. Result: The prepared formulations are free from gritty particles. Among the prepared formulations, formulation C3 containing 1.5% xanthan gum released 93.22% in 30min was found to be promising. Stability studies on the promising and other formulations indicated that there were no significant changes in the drug content and in vitro dissolution characteristics. IR spectroscopic studies indicated that there were no drug-excipient interactions. Anti-fungal studies revealed that there is no change in the molecular activity of the drug. Conclusion: The prepared jellies of Clotrimazole could stay in the mouth for a longer period of time, which indicates a potential use of jellies of Clotrimazole for treating oral candidiasis. Keywords: Clotrimazole; Jellies; Xanthan gum.

Authors and Affiliations

Keywords

Related Articles

POLYCYSTIC OVARY SYNDROME: PATHOGENESIS, TREATMENT AND SECONDARY ASSOCIATED DISEASES

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age. It is characterized by hyperandrogenism, polycystic ovaries, and chronic anovulation along with insulin resistance, hyperin...

FORMULATION AND EVALUATION OF CONTROLLED POROSITY OSMOTIC PUMP TABLETS FOR ZIDOVUDINE AND LAMIVUDINE COMBINATION USING FRUCTOSE AS OSMOGEN

The present study deals with the development and evaluation of controlled porosity osmotic pump (CPOP) tablets of zidovudine-lamivudine. Wet granulation method was used for the development of core tablets. Core tablets w...

ANALYSIS & INTERPRETATION OF PREVALENCE OF PREDIABETES WITH SPECIAL REFERENCE TO COIMBATORE

The Diabetes Mellitus patients glucose level alteration results were shown to few extent increased Glucose level with Diabetes Mellitus (18.7 ± 0.0), Type-I Diabetes Mellitus (74.5 ± 2.74), T-II Diabetes Mellitus (76.9...

Development and validation of novel HPLC method for the estimation of Rutin in crude hydromethanolic leaf extract of Prosopis cineraria

A simple, specific, accurate and precise high performance liquid chromatography method has developed for the estimation of rutin in Prosopis cineraria. The chromatographic separation was achieved by using C18 column, 150...

PHYSICAL APPROACH TO TRANSDERMAL DRUG DELIVERY: A REVIEW

Transdermal drug delivery system (TDDS) is the topically administered medication, which when applied to the skin, delivers the drug through the skin for systemic effect at a predetermined and controlled rate. For the dru...

Download PDF file
  • EP ID EP487553
  • DOI 10.22270/jddt.v6i2.1180
  • Views 69
  • Downloads 0

How To Cite

(2016). FORMULATION OF CLOTRIMAZOLE ORORETENTIVE JELLY. Journal of Drug Delivery and Therapeutics, 6(2), 21-25. https://europub.co.uk./articles/-A-487553